A prospective cohort study to explore the optimal time interval between mifepristone and misoprostol administration for medical management of early pregnancy loss. Participants will be followed to assess treatment success, satisfaction, and side effects.
Able to participate in the informed consent process and provide a signed and dated consent form.
Stated willingness to comply with all study procedures.
Access to device with text or email capability.
Able to read and understand English.
Incomplete or inevitable abortion.
Contraindication or allergy to mifepristone or misoprostol
Unable to return for clinic-based follow-up.